The results of many clinical and experimental studies have shown that neutrophils, the cells which constitute the highest percentage among all leukocytes infiltrating the tumor, show a high expression of APRIL in cancer patients (Coffelt et al. 2016; Moreaux et al. 2009). Here, TNFSF13 is linked to cancer.